chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Injection site erythema, Injection site pain
Clinical narrative: Sore arm. It is red and hot.; Sore arm. It is red and hot.; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Sore arm. It is red and hot.), INJECTION SITE ERYTHEMA (Sore arm. It is red and hot.) and INJECTION SITE PAIN (sore arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 036A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, HYDROXYZINE, PREGABALIN (LYRICA) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced FEELING HOT (Sore arm. It is red and hot.), INJECTION SITE ERYTHEMA (Sore arm. It is red and hot.) and INJECTION SITE PAIN (sore arm). At the time of the report, FEELING HOT (Sore arm. It is red and hot.), INJECTION SITE ERYTHEMA (Sore arm. It is red and hot.) and INJECTION SITE PAIN (sore arm) outcome was unknown.            No treatment information was provided. Action taken with mRNA-1273 in response to the drug was not applicable   This case was linked to MOD-2021-075283 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sensation in eye, Feeling hot, Myalgia, Nausea, Retching
Clinical narrative: sinus; heat in right nostril; achy; nauseous; heat in right eye; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of ABNORMAL SENSATION IN EYE (heat in right eye), RETCHING (dry heaves), SINUSITIS, FEELING HOT (heat in right nostril), and MYALGIA in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sinusitis.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced ABNORMAL SENSATION IN EYE (heat in right eye), RETCHING (dry heaves), FEELING HOT (heat in right nostril), MYALGIA, and NAUSEA. On an unknown date, the patient experienced SINUSITIS. The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 07-Apr-2021, RETCHING (dry heaves), MYALGIA, and NAUSEA had resolved. At the time of the report, ABNORMAL SENSATION IN EYE (heat in right eye), SINUSITIS, and FEELING HOT (heat in right nostril) had resolved.            No concomitant medication use was provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant Follow-Up. TCR attached. Events were not associated with Moderna vaccine but due to sinus problem. Outcome of events recovered/resolved. Further Follow-Up declined.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sinus; heat in right nostril; achy; nauseous; heat in right eye; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of ABNORMAL SENSATION IN EYE (heat in right eye), RETCHING (dry heaves), SINUSITIS, FEELING HOT (heat in right nostril), and MYALGIA in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sinusitis.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced ABNORMAL SENSATION IN EYE (heat in right eye), RETCHING (dry heaves), FEELING HOT (heat in right nostril), MYALGIA, and NAUSEA. On an unknown date, the patient experienced SINUSITIS. The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 07-Apr-2021, RETCHING (dry heaves), MYALGIA, and NAUSEA had resolved. At the time of the report, ABNORMAL SENSATION IN EYE (heat in right eye), SINUSITIS, and FEELING HOT (heat in right nostril) had resolved.            No concomitant medication use was provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant Follow-Up. TCR attached. Events were not associated with Moderna vaccine but due to sinus problem. Outcome of events recovered/resolved. Further Follow-Up declined.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm (arm of the injection); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm (arm of the injection)) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (esophageal). Concomitant products included LISINOPRIL, HYDROXYZINE, PREGABALIN (LYRICA) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm (arm of the injection)). On 07-Mar-2021, VACCINATION SITE PAIN (sore arm (arm of the injection)) had resolved.            Additional concomitant medication reported by the patient was acid reflux medication.  Treatment of events was reported as none.   This case was linked to MOD-2021-075280 (Patient Link).   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Malaise
Clinical narrative: got covid; felt ill; excruciating headaches; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of COVID-19 (got covid), MALAISE (very bad and felt ill) and HEADACHE (excruciating headaches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMIN [VITAMINS NOS] and MAGNESIUM for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced COVID-19 (got covid), MALAISE (very bad and felt ill) and HEADACHE (excruciating headaches). On 04-Apr-2021, COVID-19 (got covid) and MALAISE (very bad and felt ill) had resolved. On 10-Apr-2021, HEADACHE (excruciating headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported she was  given an intravenous infusion to treat Covid infection all day at a clinic on an unknown date.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Freezing phenomenon, Influenza like illness, Injection site erythema, Injection site swelling
Clinical narrative: flu like symptoms; Freezing phenomenon; Chills; Nauseous; Injection site swelling; Injection site erythema; Injection site warmth; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Injection site warmth), INFLUENZA LIKE ILLNESS (flu like symptoms), FREEZING PHENOMENON (Freezing phenomenon), CHILLS (Chills) and NAUSEA (Nauseous) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced INJECTION SITE WARMTH (Injection site warmth), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (Injection site erythema). 26-Mar-2021, the patient experienced NAUSEA (Nauseous). On 27-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), FREEZING PHENOMENON (Freezing phenomenon) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 09-Apr-2021, NAUSEA (Nauseous) had resolved. At the time of the report, INJECTION SITE WARMTH (Injection site warmth), INFLUENZA LIKE ILLNESS (flu like symptoms), FREEZING PHENOMENON (Freezing phenomenon), CHILLS (Chills), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (Injection site erythema) outcome was unknown.            The patient reported concomitant medication use of female hormones and cholesterol medication both for unknown indications since unknown start dates. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-075275 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075275:CROSSLINKED WITH DOSE 1
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Nausea
Clinical narrative: flu like symptoms; Freezing phenomenon; Chills; Nauseous; Injection site swelling; Injection site erythema; Injection site warmth; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Injection site warmth), INFLUENZA LIKE ILLNESS (flu like symptoms), FREEZING PHENOMENON (Freezing phenomenon), CHILLS (Chills) and NAUSEA (Nauseous) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced INJECTION SITE WARMTH (Injection site warmth), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (Injection site erythema). 26-Mar-2021, the patient experienced NAUSEA (Nauseous). On 27-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), FREEZING PHENOMENON (Freezing phenomenon) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 09-Apr-2021, NAUSEA (Nauseous) had resolved. At the time of the report, INJECTION SITE WARMTH (Injection site warmth), INFLUENZA LIKE ILLNESS (flu like symptoms), FREEZING PHENOMENON (Freezing phenomenon), CHILLS (Chills), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE ERYTHEMA (Injection site erythema) outcome was unknown.            The patient reported concomitant medication use of female hormones and cholesterol medication both for unknown indications since unknown start dates. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-075275 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075275:CROSSLINKED WITH DOSE 1
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu-like symptoms after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms after 1st dose) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Previously administered products included for an unreported indication: PNEUMOCOCCAL VACCINE in March 2021 and INFLUENZA VACCINE in March 2021. Concurrent medical conditions included Reaction to previous exposure to any vaccine.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms after 1st dose). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms after 1st dose) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.   No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-075311 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075311:2nd dose
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pruritus, Vaccination site swelling
Clinical narrative: Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats; Itching that she has; Left arm swelling at the injection site and she feels that the swelling; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats), PRURITUS (Itching that she has) and VACCINATION SITE SWELLING (Left arm swelling at the injection site and she feels that the swelling) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 063A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats), PRURITUS (Itching that she has) and VACCINATION SITE SWELLING (Left arm swelling at the injection site and she feels that the swelling). At the time of the report, HEART RATE INCREASED (Taken her 2nd dose of the Moderna vaccine and she is experiencing fast heartbeats), PRURITUS (Itching that she has) and VACCINATION SITE SWELLING (Left arm swelling at the injection site and she feels that the swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not provided. Action taken with the drug in response to the event is not applicable.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Disturbance in attention, Dizziness, Dyspnoea, Fatigue
Clinical narrative: headache; kind of dizzy; felt really tired; couldn't concentrate super well; hard to breath for 1 minute; A tight chest for 1 minute; his eyes got puffy; his eyes got red; felt like if someone pushed his arm a couple of hours later; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like if someone pushed his arm a couple of hours later), DYSPNOEA (hard to breath for 1 minute), CHEST DISCOMFORT (A tight chest for 1 minute), PERIORBITAL SWELLING (his eyes got puffy) and OCULAR HYPERAEMIA (his eyes got red) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic kidney disease stage 3 (Chronic kidney disease stage 3). Concomitant products included LISINOPRIL, ATORVASTATIN and FISH OIL for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FEELING ABNORMAL (felt like if someone pushed his arm a couple of hours later). On 11-Apr-2021, the patient experienced DYSPNOEA (hard to breath for 1 minute), CHEST DISCOMFORT (A tight chest for 1 minute), PERIORBITAL SWELLING (his eyes got puffy) and OCULAR HYPERAEMIA (his eyes got red). On 12-Apr-2021, the patient experienced DISTURBANCE IN ATTENTION (couldn't concentrate super well) and FATIGUE (felt really tired). On 13-Apr-2021, the patient experienced DIZZINESS (kind of dizzy). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, FEELING ABNORMAL (felt like if someone pushed his arm a couple of hours later), DYSPNOEA (hard to breath for 1 minute), CHEST DISCOMFORT (A tight chest for 1 minute), PERIORBITAL SWELLING (his eyes got puffy), OCULAR HYPERAEMIA (his eyes got red), DISTURBANCE IN ATTENTION (couldn't concentrate super well), DIZZINESS (kind of dizzy), FATIGUE (felt really tired) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Ocular hyperaemia, Periorbital swelling
Clinical narrative: headache; kind of dizzy; felt really tired; couldn't concentrate super well; hard to breath for 1 minute; A tight chest for 1 minute; his eyes got puffy; his eyes got red; felt like if someone pushed his arm a couple of hours later; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like if someone pushed his arm a couple of hours later), DYSPNOEA (hard to breath for 1 minute), CHEST DISCOMFORT (A tight chest for 1 minute), PERIORBITAL SWELLING (his eyes got puffy) and OCULAR HYPERAEMIA (his eyes got red) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic kidney disease stage 3 (Chronic kidney disease stage 3). Concomitant products included LISINOPRIL, ATORVASTATIN and FISH OIL for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FEELING ABNORMAL (felt like if someone pushed his arm a couple of hours later). On 11-Apr-2021, the patient experienced DYSPNOEA (hard to breath for 1 minute), CHEST DISCOMFORT (A tight chest for 1 minute), PERIORBITAL SWELLING (his eyes got puffy) and OCULAR HYPERAEMIA (his eyes got red). On 12-Apr-2021, the patient experienced DISTURBANCE IN ATTENTION (couldn't concentrate super well) and FATIGUE (felt really tired). On 13-Apr-2021, the patient experienced DIZZINESS (kind of dizzy). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, FEELING ABNORMAL (felt like if someone pushed his arm a couple of hours later), DYSPNOEA (hard to breath for 1 minute), CHEST DISCOMFORT (A tight chest for 1 minute), PERIORBITAL SWELLING (his eyes got puffy), OCULAR HYPERAEMIA (his eyes got red), DISTURBANCE IN ATTENTION (couldn't concentrate super well), DIZZINESS (kind of dizzy), FATIGUE (felt really tired) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Cough, Influenza, Lacrimation increased
Clinical narrative: patient started with flu for 8 days; He suffered from constant lingering cough; chest ache; Back ache; both arm ache; His eyes started watering; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (patient started with flu for 8 days), COUGH (He suffered from constant lingering cough), CHEST PAIN (chest ache), BACK PAIN (Back ache) and PAIN IN EXTREMITY (both arm ache) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Medical history).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced INFLUENZA (patient started with flu for 8 days), COUGH (He suffered from constant lingering cough), CHEST PAIN (chest ache), BACK PAIN (Back ache), PAIN IN EXTREMITY (both arm ache) and LACRIMATION INCREASED (His eyes started watering). At the time of the report, INFLUENZA (patient started with flu for 8 days), COUGH (He suffered from constant lingering cough), CHEST PAIN (chest ache), BACK PAIN (Back ache), PAIN IN EXTREMITY (both arm ache) and LACRIMATION INCREASED (His eyes started watering) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: (Negative) Negative.         Action taken with Suspect product was Not Applicable.       Reporter did not allow further contact
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test negative
Clinical narrative: patient started with flu for 8 days; He suffered from constant lingering cough; chest ache; Back ache; both arm ache; His eyes started watering; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (patient started with flu for 8 days), COUGH (He suffered from constant lingering cough), CHEST PAIN (chest ache), BACK PAIN (Back ache) and PAIN IN EXTREMITY (both arm ache) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Medical history).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced INFLUENZA (patient started with flu for 8 days), COUGH (He suffered from constant lingering cough), CHEST PAIN (chest ache), BACK PAIN (Back ache), PAIN IN EXTREMITY (both arm ache) and LACRIMATION INCREASED (His eyes started watering). At the time of the report, INFLUENZA (patient started with flu for 8 days), COUGH (He suffered from constant lingering cough), CHEST PAIN (chest ache), BACK PAIN (Back ache), PAIN IN EXTREMITY (both arm ache) and LACRIMATION INCREASED (His eyes started watering) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: (Negative) Negative.         Action taken with Suspect product was Not Applicable.       Reporter did not allow further contact
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Heart rate increased, Panic attack
Clinical narrative: Panic attack; Heart rate increased; Chest tightness; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart rate increased), CHEST DISCOMFORT (Chest tightness) and PANIC ATTACK (Panic attack) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Palpitations, Palpitations, Reaction hypersensitivity (NOS) and Panic attack. Previously administered products included for an unreported indication: BETA BLOCKING AGENTS.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced HEART RATE INCREASED (Heart rate increased) and CHEST DISCOMFORT (Chest tightness). On an unknown date, the patient experienced PANIC ATTACK (Panic attack). At the time of the report, HEART RATE INCREASED (Heart rate increased), CHEST DISCOMFORT (Chest tightness) and PANIC ATTACK (Panic attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications an treatment information were reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Well over 6 weeks since patient received first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Well over 6 weeks since patient received first dose) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Well over 6 weeks since patient received first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Well over 6 weeks since patient received first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided. .
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine stored improperly; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine stored improperly) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021 at 2:35 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine stored improperly). On 13-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine stored improperly) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications or treatments were reported.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: shortness of breath; light congestion; loss of appetite; cough; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), NASAL CONGESTION (light congestion), DECREASED APPETITE (loss of appetite), COUGH (cough) and FATIGUE (fatigue) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced DYSPNOEA (shortness of breath), NASAL CONGESTION (light congestion), DECREASED APPETITE (loss of appetite), COUGH (cough), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DYSPNOEA (shortness of breath), NASAL CONGESTION (light congestion), DECREASED APPETITE (loss of appetite), COUGH (cough), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown. Not Provided
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion
Clinical narrative: shortness of breath; light congestion; loss of appetite; cough; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), NASAL CONGESTION (light congestion), DECREASED APPETITE (loss of appetite), COUGH (cough) and FATIGUE (fatigue) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced DYSPNOEA (shortness of breath), NASAL CONGESTION (light congestion), DECREASED APPETITE (loss of appetite), COUGH (cough), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DYSPNOEA (shortness of breath), NASAL CONGESTION (light congestion), DECREASED APPETITE (loss of appetite), COUGH (cough), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown. Not Provided
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Heart rate increased
Clinical narrative: dizzy; weak; rapid heartbeat; don't feel well; lot of pain inside both legs. it hurts; Pain in her left site; tired; all her body is hurting; headache; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (dizzy), ASTHENIA (weak), HEART RATE INCREASED (rapid heartbeat), MALAISE (don't feel well) and PAIN IN EXTREMITY (lot of pain inside both legs. it hurts) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Medical history).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy), ASTHENIA (weak), HEART RATE INCREASED (rapid heartbeat), MALAISE (don't feel well), PAIN IN EXTREMITY (lot of pain inside both legs. it hurts), PAIN (Pain in her left site), FATIGUE (tired), MYALGIA (all her body is hurting) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), ASTHENIA (weak), HEART RATE INCREASED (rapid heartbeat), MALAISE (don't feel well), PAIN IN EXTREMITY (lot of pain inside both legs. it hurts), PAIN (Pain in her left site), FATIGUE (tired), MYALGIA (all her body is hurting) and HEADACHE (headache) outcome was unknown. Not Provided          Treatment medication was Acetaminophen.   Reporter did not allow further contact
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Pain, Pain in extremity
Clinical narrative: dizzy; weak; rapid heartbeat; don't feel well; lot of pain inside both legs. it hurts; Pain in her left site; tired; all her body is hurting; headache; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (dizzy), ASTHENIA (weak), HEART RATE INCREASED (rapid heartbeat), MALAISE (don't feel well) and PAIN IN EXTREMITY (lot of pain inside both legs. it hurts) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported Medical history).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy), ASTHENIA (weak), HEART RATE INCREASED (rapid heartbeat), MALAISE (don't feel well), PAIN IN EXTREMITY (lot of pain inside both legs. it hurts), PAIN (Pain in her left site), FATIGUE (tired), MYALGIA (all her body is hurting) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), ASTHENIA (weak), HEART RATE INCREASED (rapid heartbeat), MALAISE (don't feel well), PAIN IN EXTREMITY (lot of pain inside both legs. it hurts), PAIN (Pain in her left site), FATIGUE (tired), MYALGIA (all her body is hurting) and HEADACHE (headache) outcome was unknown. Not Provided          Treatment medication was Acetaminophen.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Candida infection, Fatigue, Nausea
Clinical narrative: Thrush; Nausea; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CANDIDA INFECTION (Thrush), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CANDIDA INFECTION (Thrush), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, CANDIDA INFECTION (Thrush) outcome was unknown and NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. Not Provided          No relevant concomitant medications were reported. Treatment information included medication to treat thrust. Action taken with mRNA-1273 in response to the events was not applicable. On 20-Mar-2021 the patient went to the ER and was diagnosed with thrush which had been going on for 3 and half weeks, and patient took medication for thrust treatment.She went to the Doctor and did lab culture and result was negative (showed no thrush).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: feels like she was hit by a mack-truck/semi-truck/ pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (feels like she was hit by a mack-truck/semi-truck/ pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN (feels like she was hit by a mack-truck/semi-truck/ pain). At the time of the report, PAIN (feels like she was hit by a mack-truck/semi-truck/ pain) outcome was unknown. Not Provided          No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Feeling abnormal, Pain in extremity
Clinical narrative: Pain in arm; Feels like she's not breathing as good as she use to; Aches in joints; Strange feeling from the waist up after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), DYSPNOEA (Feels like she's not breathing as good as she use to), ARTHRALGIA (Aches in joints) and FEELING ABNORMAL (Strange feeling from the waist up after 2nd dose) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Previously administered products included for Product used for unknown indication: Pneumococcal vaccine in March 2021 and Flu vaccine in March 2021. Past adverse reactions to the above products included Reaction allergic (NOS) with Flu vaccine.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm), DYSPNOEA (Feels like she's not breathing as good as she use to), ARTHRALGIA (Aches in joints) and FEELING ABNORMAL (Strange feeling from the waist up after 2nd dose). At the time of the report, PAIN IN EXTREMITY (Pain in arm), DYSPNOEA (Feels like she's not breathing as good as she use to), ARTHRALGIA (Aches in joints) and FEELING ABNORMAL (Strange feeling from the waist up after 2nd dose) outcome was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness, Nausea, Somnolence
Clinical narrative: His whole right side is sore; Feels like he had flu; Drowsy every morning; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Feels like he had flu), SOMNOLENCE (Drowsy every morning), NAUSEA (Nauseated) and ARTHRALGIA (His whole right side is sore) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Shoulder discomfort.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Feels like he had flu), SOMNOLENCE (Drowsy every morning) and NAUSEA (Nauseated). On an unknown date, the patient experienced ARTHRALGIA (His whole right side is sore). At the time of the report, INFLUENZA LIKE ILLNESS (Feels like he had flu), SOMNOLENCE (Drowsy every morning), NAUSEA (Nauseated) and ARTHRALGIA (His whole right side is sore) outcome was unknown.            No concomitant medications were reported.   The patient reported having an issue with his shoulder before having the dose and  was unsure if it is due to the vaccine or previous shoulder issue.  The patient did not use any treatment for the events.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Fatigue, Upper respiratory tract infection
Clinical narrative: upper respiratory infection; exacerbated asthma/Asthma worsened / could not breathe at night; Achy joints; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection), ASTHMA (exacerbated asthma/Asthma worsened / could not breathe at night), ARTHRALGIA (Achy joints) and FATIGUE (Fatigue) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since 1979, Disability and Fibromyalgia.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced ARTHRALGIA (Achy joints) and FATIGUE (Fatigue). On 09-Apr-2021, the patient experienced ASTHMA (exacerbated asthma/Asthma worsened / could not breathe at night). On 20-Apr-2021, the patient experienced UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection). The patient was treated with AZITHROMYCIN on 20-Apr-2021 for Upper respiratory infection, at an unspecified dose and frequency and PREDNISONE for Asthma aggravated, at an unspecified dose and frequency. On 09-Apr-2021, ARTHRALGIA (Achy joints) and FATIGUE (Fatigue) had resolved. At the time of the report, UPPER RESPIRATORY TRACT INFECTION (upper respiratory infection) and ASTHMA (exacerbated asthma/Asthma worsened / could not breathe at night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On Friday, 09-Apr-2021, asthma worsened and the patient was prescribed prednisone. The patient had asthma since 12 years of age but never to the extent where she could not breathe at night. She reported using a nebulizer.    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Added event (upper respiratory infection) and treatment drug (azithromycin).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Vaccination site induration, Vaccination site irritation, Vaccination site pain
Clinical narrative: injection site seemed irritated and tender; headaches; injection site seemed irritated and tender; at and around the injection site it has swollen up to the size of a marble; the area is hard; experienced sleeplessness; does suffer with slight boughts of insomnia; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (experienced sleeplessness; does suffer with slight boughts of insomnia), VACCINATION SITE IRRITATION (injection site seemed irritated and tender), VACCINATION SITE INDURATION (the area is hard), HEADACHE (headaches) and VACCINATION SITE PAIN (injection site seemed irritated and tender) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INSOMNIA (experienced sleeplessness; does suffer with slight boughts of insomnia). On 13-Apr-2021, the patient experienced VACCINATION SITE INDURATION (the area is hard) and VACCINATION SITE SWELLING (at and around the injection site it has swollen up to the size of a marble). On an unknown date, the patient experienced VACCINATION SITE IRRITATION (injection site seemed irritated and tender), HEADACHE (headaches) and VACCINATION SITE PAIN (injection site seemed irritated and tender). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at a dose of 1 dosage form once a day. At the time of the report, INSOMNIA (experienced sleeplessness; does suffer with slight boughts of insomnia), VACCINATION SITE IRRITATION (injection site seemed irritated and tender), VACCINATION SITE INDURATION (the area is hard), HEADACHE (headaches), VACCINATION SITE PAIN (injection site seemed irritated and tender) and VACCINATION SITE SWELLING (at and around the injection site it has swollen up to the size of a marble) outcome was unknown.            Concomitant medication was not provided by the reporter.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: injection site seemed irritated and tender; headaches; injection site seemed irritated and tender; at and around the injection site it has swollen up to the size of a marble; the area is hard; experienced sleeplessness; does suffer with slight boughts of insomnia; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (experienced sleeplessness; does suffer with slight boughts of insomnia), VACCINATION SITE IRRITATION (injection site seemed irritated and tender), VACCINATION SITE INDURATION (the area is hard), HEADACHE (headaches) and VACCINATION SITE PAIN (injection site seemed irritated and tender) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INSOMNIA (experienced sleeplessness; does suffer with slight boughts of insomnia). On 13-Apr-2021, the patient experienced VACCINATION SITE INDURATION (the area is hard) and VACCINATION SITE SWELLING (at and around the injection site it has swollen up to the size of a marble). On an unknown date, the patient experienced VACCINATION SITE IRRITATION (injection site seemed irritated and tender), HEADACHE (headaches) and VACCINATION SITE PAIN (injection site seemed irritated and tender). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at a dose of 1 dosage form once a day. At the time of the report, INSOMNIA (experienced sleeplessness; does suffer with slight boughts of insomnia), VACCINATION SITE IRRITATION (injection site seemed irritated and tender), VACCINATION SITE INDURATION (the area is hard), HEADACHE (headaches), VACCINATION SITE PAIN (injection site seemed irritated and tender) and VACCINATION SITE SWELLING (at and around the injection site it has swollen up to the size of a marble) outcome was unknown.            Concomitant medication was not provided by the reporter.    Reporter did not allow further contact
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Vaccination site lymphadenopathy
Clinical narrative: lymph node more sensitive to touch; swollen lymphnode in the left arm where he got the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swollen lymphnode in the left arm where he got the vaccine) and LYMPH NODE PAIN (lymph node more sensitive to touch) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymphnode in the left arm where he got the vaccine). On 13-Apr-2021, the patient experienced LYMPH NODE PAIN (lymph node more sensitive to touch). The patient was treated with IBUPROFEN for Swollen lymph nodes, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymphnode in the left arm where he got the vaccine) and LYMPH NODE PAIN (lymph node more sensitive to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication used.